Healthcare >> Analyst Interviews >> September 17, 2004
LIBBE ENGLANDER is a Senior Portfolio manager for BioPharma Capital, a
European healthcare fund management company owned by IT Asset
Management, a subsidiary of Raymond James. Dr. Englander co-manages
ITAM's mutual fund that invests primarily in late stage US biotechnology
companies. She co-founded BioPharma Capital in 2000. Prior to this, she
founded EME Biology, a consulting firm that provided information and
strategic planning services to the biotech industry. She has a PhD from
Rockefeller University and a BS in Biology from Yale. Profile
TWST: Would you start us off with a quick overview of Biopharma Capital?Dr. Englander: BioPharma Capital is a European healthcare fund
management company owned by IT Asset Management, a